BVNRY catalysts
Catalysts and events linked to BVNRY, newest first.
BVNRY stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capital 2026-10-19 · Up | open-market buyback reducing free float shares | Repurchases total 5.53% of share capital under active DKK 250M program. | Not recorded |
| Bavarian Nordic raises 2026 Travel Health outlook to DKK 3.4B on US rabies vaccine sales 2026-10-08 · Up | guidance upgrade lifting full-year pharmaceutical revenue expectations | Travel Health revenue guidance raised by DKK 400M on strong US rabies vaccine sales. | Not recorded |
| Bavarian Nordic Lifts 2026 Travel Health Revenue Guidance to DKK 3.4B 2026-10-08 · Up | segment revenue upgrade and operational margin expansion | Management raised segment guidance by DKK 400 million on US demand. | Not recorded |
| Bavarian Nordic Raises 2026 Travel Health Revenue Guidance to DKK 3.4B 2026-10-08 · Up | guidance upgrade lifting 2026 operating cash flow and revenue consensus | Travel Health revenue guidance raised to DKK 3,400M from DKK 3,000M. | Not recorded |
| Bavarian Nordic Raises 2026 Guidance on U.S. Travel Health Revenue Strength 2026-10-08 · Up | higher full-year revenue and operating margin revisions | Guidance raised Travel Health revenue to DKK 3,400 million from DKK 3,000 million. | Not recorded |
| Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine Demand 2026-10-08 · Up | operating revenue expansion from specialty vaccine demand | Bavarian Nordic raised Travel Health revenue expectations to DKK 3,400 million from DKK 3,000 million. | Not recorded |
| Bavarian Nordic Repurchases 5.07% of Share Capital Under DKK 250M Program 2026-09-28 · Up | float reduction and EPS accretion from 5.07% share capital retirement | Source confirms accumulated share repurchases of 459,322 shares representing 5.07% of share capital | Not recorded |
| Bavarian Nordic Reaches 5.07% Capital Repurchased Under DKK 250M Program 2026-09-28 · Up | direct share capital contraction via corporate equity buyback | Bavarian Nordic accumulated 459,322 repurchased shares representing 5.07% of share capital. | Not recorded |
Do these developments change your position?
Review BVNRY alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-10-19Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capitalBVNRY
- 2026-10-19Bavarian Nordic advances DKK 250M buyback, reaching 5.53% of capitalBVNRY
- 2026-10-08Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine DemandBVNRY+2.61%
- 2026-10-08Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine DemandBVNRY+2.61%
- 2026-10-08Bavarian Nordic Lifts 2026 Travel Health Revenue Guidance to DKK 3.4BBVNRY+2.61%
- 2026-10-08Bavarian Nordic Raises 2026 Guidance on U.S. Travel Health Revenue StrengthBVNRY+2.61%
- 2026-10-08Bavarian Nordic Lifts 2026 Revenue Outlook on US Vaccine DemandBVNRY+2.61%
- 2026-10-08Bavarian Nordic raises 2026 Travel Health outlook to DKK 3.4B on US rabies vaccine salesBVNRY+2.61%
- 2026-10-08Bavarian Nordic Raises 2026 Travel Health Revenue Guidance to DKK 3.4BBVNRY+2.61%
- 2026-10-08Bavarian Nordic Raises 2026 Guidance on U.S. Travel Health Revenue StrengthBVNRY+2.61%
- 2026-10-08Bavarian Nordic Lifts 2026 Travel Health Revenue Guidance to DKK 3.4BBVNRY+2.61%
- 2026-09-28Bavarian Nordic Deploys DKK 96.9M Repurchasing 459,322 Shares Under BuybackBVNRY-0.13%
- 2026-09-28Bavarian Nordic Advances DKK 250M Buyback, Treasury Holdings Reach 5.07% of CapitalBVNRY-0.13%
- 2026-09-28Bavarian Nordic Buys Back 57,000 Shares, Reaching 5.07% Capital Repurchase TotalBVNRY-0.13%
- 2026-09-28Bavarian Nordic accumulates 5.07% in treasury shares under DKK 250M repurchase programBVNRY-0.13%
- 2026-09-28Bavarian Nordic Reaches 5.07% Capital Repurchased Under DKK 250M ProgramBVNRY-0.13%
- 2026-09-28Bavarian Nordic Reaches 5.07% Capital Repurchased Under DKK 250M ProgramBVNRY-0.13%
- 2026-09-28Bavarian Nordic Repurchases 5.07% of Share Capital Under DKK 250M ProgramBVNRY-0.13%
- 2026-09-21Bavarian Nordic Reaches 5.0% Treasury Share Threshold in DKK 250M BuybackBVNRY+2.81%
- 2026-09-21Bavarian Nordic Reaches 5.0% Treasury Share Threshold in DKK 250M BuybackBVNRY+2.81%
- 2026-09-17Bavarian Nordic Appoints Tarja Stenvall as CEO Effective October 15, 2026BVNRY+4.59%
- 2026-09-17Bavarian Nordic Appoints Tarja Stenvall as CEO Effective October 15, 2026BVNRY+4.59%
- 2026-09-17Bavarian Nordic Appoints Tarja Stenvall as CEO Effective October 15, 2026BVNRY+4.59%
- 2026-09-01Bavarian Nordic Commences DKK 750M Repurchase Program TrancheBVNRY-8.17%
- 2026-09-01Bavarian Nordic Commences DKK 750M Share Buyback ProgramBVNRY-8.17%
- 2026-09-01Bavarian Nordic Commences DKK 750M Repurchase Program TrancheBVNRY-8.17%
- 2026-09-01Bavarian Nordic Initiates DKK 750M Share Buyback With DKK 250M TrancheBVNRY-8.17%
- 2026-07-13Bavarian Nordic Submits Chikungunya Vaccine for Regulatory Approval in BrazilBVNRY+1.26%
- 2026-07-13Bavarian Nordic Submits Chikungunya Vaccine for Regulatory Approval in BrazilBVNRY+1.26%
- 2026-07-06Bavarian Nordic Completes DKK 120.5 Million Share BuybackBVNRY-4.82%
- 2026-07-06Bavarian Nordic Completes DKK 120.5 Million Share BuybackBVNRY-4.82%
- 2026-06-29Bavarian Nordic Completes DKK 83M of Share Buyback ProgramBVNRY+3.07%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.